Under construction – not a live service
Sign in
Taking people in SwedenNo phase

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

Key facts

Where
Malmö, SwedenSee the site

Where in Sweden

  • Clinical Research CenterMalmö, SwedenTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Region Skane
Trial code
NCT07659535
Record updated
25 June 2026
Original description
The overall aim of the study is to investigate the incidence of type 2 diabetes in individuals who have access to a digital intervention tool as compared with randomized controls during three years. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.Read full original descriptionShow less

Personalized Study With the Lifestyle Tool

The overall aim of the study is to investigate the incidence of type 2 diabetes in individuals who have access to a digital intervention tool as compared with randomized controls during three years. The tool is based on self-affirmation theory and has large emphasis on self-reflection to enable sustainable lifestyle changes. Users get access to expert-written information about relevant health topics and interact with an LLM to promote reflection on the information.

Inclusion: Informed consent; Age above 35 years; Access to Internet and mobile or computer device.

Exclusion: diabetes mellitus; conditions or treatments that in the judgement of the Investigator could affect the study evaluation; connection with the study team, funders, authorities, universities or other public or private bodies in such a way that specific interests in the study outcomes could be suspected; living outside of Sweden; inability to read and write in Swedish.

ClinicalTrials.gov NCT07659535